Baseline demographic and disease-related information for 246 patients with fibromyalgia. Data are n (%) or mean ± SD.
| Characteristic | Total, n = 246 |
|---|---|
| Age, yrs | 47.8 ± 10.4 |
| Sex | |
| Female | 224 (91) |
| Male | 22 (9) |
| Marital status | |
| Single | 53 (22) |
| Married | 153 (63) |
| Divorced | 27 (11) |
| Widowed | 9 (4) |
| Employment status | |
| Employed | 89 (36) |
| Unemployed | 80 (33) |
| Disabled | 77 (31) |
| Cigarette use | 56 (23) |
| Cannabinoid use | 18 (7) |
| Alcohol abuse | 11 (5) |
| Drug abuse | 11 (5) |
| Medication count | 2.6 ± 1.3 |
| Alternative product use | 13 (5) |
| Complementary practitioner treatment | 37 (15) |
| Pain duration, yrs | 10.8 ± 9.8 |
| Pain VAS | 6.5 ± 2.3 |
| PGA | 6.7 ± 2.1 |
| MPQ | 41.0 ± 15.1 |
| PDI | 37.6 ± 14.5 |
| PCS | 29.3 ± 12.2 |
| FIQ | 67.0 ± 16.8 |
| HAQ | 1.19 ± 0.6 |
| AIMS anxiety | 6.3 ± 1.8 |
| AIMS depression | 4.9 ± 1.8 |
VAS: visual analog scale; PGA: patient global assessment of disease activity; MPQ: McGill Pain Questionnaire; PDI: Pain Disability Index; PCS: Pain Catastrophizing Scale; FIQ: Fibromyalgia Impact Questionnaire; HAQ: Health Assessment Questionnaire; AIMS: Arthritis Impact Measurement Scale.